Concentration (105 cells ml−1) of haemocyte sub-populations in C. gigas hemolymph samples during DCFH-DA analysis
. | 18°C . | . | . | 30°C . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
. | C. calcitrans . | T. suecica . | T-Iso . | C. calcitrans . | T. suecica . | T-Iso . | ||||
Control condition | ||||||||||
Granulocytes | 1.0±0.05b,A | 0.6±0.3a,b,A | 0.5±0.2a,A | 1.1±0.04b,A | 0.6±0.2a,A | 0.5±0.2a,A | ||||
Hyalinocytes | 2.0±0.2a,A | 1.4±0.2a,A | 1.5±0.2a,A | 2.3±0.2b,A | 1.5±0.3a,A | 1.6±0.2a,A | ||||
Small agranular cells | 1.1±0.1a,A | 0.8±0.2a,A | 0.9±0.3a,A | 1.1±0.1a,A | 0.9±0.3a,A | 0.9±0.2a,A | ||||
With PMA | ||||||||||
Granulocytes | 0.4±0.1a,B | 0.5±0.2a,A | 0.3±0.1a,A | 0.5±0.1a,B | 0.4±0.1a,A | 0.3±0.1a,A | ||||
Hyalinocytes | 1.6±0.3a,A | 1.3±0.4a,A | 1.2±0.1a,A | 1.8±0.4a,A | 1.3±0.2a,A | 1.3±0.1a,A | ||||
Small agranular cells | 0.9±0.1a,A | 0.9±0.3a,A | 0.8±0.2a,A | 0.8±0.1a,A | 0.8±0.2a,A | 0.7±0.2a,A |
. | 18°C . | . | . | 30°C . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
. | C. calcitrans . | T. suecica . | T-Iso . | C. calcitrans . | T. suecica . | T-Iso . | ||||
Control condition | ||||||||||
Granulocytes | 1.0±0.05b,A | 0.6±0.3a,b,A | 0.5±0.2a,A | 1.1±0.04b,A | 0.6±0.2a,A | 0.5±0.2a,A | ||||
Hyalinocytes | 2.0±0.2a,A | 1.4±0.2a,A | 1.5±0.2a,A | 2.3±0.2b,A | 1.5±0.3a,A | 1.6±0.2a,A | ||||
Small agranular cells | 1.1±0.1a,A | 0.8±0.2a,A | 0.9±0.3a,A | 1.1±0.1a,A | 0.9±0.3a,A | 0.9±0.2a,A | ||||
With PMA | ||||||||||
Granulocytes | 0.4±0.1a,B | 0.5±0.2a,A | 0.3±0.1a,A | 0.5±0.1a,B | 0.4±0.1a,A | 0.3±0.1a,A | ||||
Hyalinocytes | 1.6±0.3a,A | 1.3±0.4a,A | 1.2±0.1a,A | 1.8±0.4a,A | 1.3±0.2a,A | 1.3±0.1a,A | ||||
Small agranular cells | 0.9±0.1a,A | 0.9±0.3a,A | 0.8±0.2a,A | 0.8±0.1a,A | 0.8±0.2a,A | 0.7±0.2a,A |
DCFH-DA, 2′7′ -dichlorofluorescein diacetate; PMA, phorbol myristate acetate.
Different lower-case letters indicate significant difference between dietary treatments. Different upper-case letters indicate a significant effect of the analysis conditions (control vs PMA; mean ± s.d., N=3, ANOVA P<0.01 for dietary treatment; t-test P<0.05 for the PMA effect).